(Press-News.org) Researchers at the University of California, San Diego School of Medicine have identified 13 metabolites – small molecules produced by cellular metabolism – that are significantly different in patients with diabetes and chronic kidney disease compared to healthy controls.
Twelve of the 13 metabolites are linked to mitochondrial function, suggesting that suppression of mitochondria – the powerhouses of cells – is a fundamental characteristic of diabetic kidney disease. The findings are published in the November edition of the Journal of the American Society of Nephrology.
"This work provides strong evidence that reduced mitochondrial function is a dominant feature of human diabetic kidney disease," said first author Kumar Sharma, MD, professor of medicine and director of the Center for Renal Translational Medicine at UC San Diego. "We found that a specific cellular pathway, AMPK-PGC1a, likely plays a key role to reduce mitochondrial function and content, which means that new therapeutic approaches that restore and increase mitochondrial function and content could ameliorate or perhaps even arrest chronic kidney disease."
Diabetic kidney disease is the leading cause of end-stage kidney disease, which is the eighth leading cause of death in the United States and a major risk factor for cardiovascular disease, the nation's leading killer. An estimated 26 million American adults have chronic kidney disease (CKD), with millions more at increased risk. These patients often require dialysis or an organ transplant.
The primary causes of CKD are high blood pressure and diabetes. Rates of both CKD and diabetes have risen dramatically in the last decade, particularly among people aged 65 and older. According to the National Kidney and Urologic Diseases Information Clearinghouse, the annual mortality rate for end-stage renal disease rose from 10,478 in 1980 to 90,118 in 2009, though it has declined somewhat in recent years.
After analyzing a total of 193 urine samples from patients with diabetes and CKD, diabetes but no CKD and healthy controls with neither condition, Sharma and colleagues quantified 94 metabolites in the samples. Thirteen metabolites were significantly different between patients with diabetes and CKD versus controls. Twelve remained significant when compared to patients with diabetes but not CKD. Twelve metabolites play a role in mitochondrial metabolism and were present in lower levels in patients with diabetes and CKD, suggesting that this major diabetic complication is at least partly the consequence of suppressed mitochondrial activity.
Sharma said measuring urine metabolites to detect and assess diabetic kidney disease is a major diagnostic step forward. "The urine metabolites can indicate the underlying function of the kidney at a biochemical and intracellular level," he said, "and are well-conserved compared to many cell-based and protein measurements. Urine metabolomics also offers an opportunity to gauge effects of new treatments which will be an advantage to guide precision medicine."
INFORMATION:
Co-authors include Bethany Karl and Maggie Diamond-Stanic, UCSD Institute of Metabolic Medicine, UCSD Center for Renal Translational Medicine and Division of Nephology-Hypertension, VA San Diego Healthcare System; Anna V. Mathew, UCSD Center for Renal Translational Medicine and Division of Nephology-Hypertension, VA San Diego Healthcare System, now at the University of Michigan; Jon A. Gangoiti, Bruce Barshop, William Nyhan, Biochemical Genetics Program and Institute of Metabolomic Medicine, UCSD; Christina L. Wassel and Minya Pu, Department of Family and Preventive Medicine, UCSD; Rintaro Saito, UCSD Institute of Metabolic Medicine, UCSD Center for Renal Translational Medicine and Division of Medical Genetics, UCSD; Shoba Sharma and Young You, UCSD Center for Renal Translational Medicine; Lin Wang, Mitochondrial and Metabolic Disease Center, UCSD; Maja T. Lindenmeyer and Clemens D. Cohen Division of Nephology, University Hospital Zurich, Switzerland; Carol Forsblom, Folkhalsan Institute of Genetics, Helsinki Finland; Wei Wu and Sanjay K. Nigam, Departments of Pediatrics and Cell and Molecular Medicine, UCSD; Joachim H. Ix, Division of Nephology-Hypertension, VA San Diego Healthcare System, UCSD Center for Renal Translational Medicine; Trey Ideker, Division of Medical Genetics, UCSD; Jeffrey B. Koop, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health; Per-Henrik Groop, Folkhalsan Institute of Genetics, Helsinki, Finland and IDI Baker Heart and Diabetes Institute, Melbourne, Australia; Loki Natarajan, UCSD Institute of Metabolomic Medicine and Department of Family and Preventive Medicine, UCSD; and Robert K. Naviaux, Mitochondrial and Metabolic Disease Center, UCSD, UCSD Institute of Metabolomic Medicine, Division of Medical Genetics, UCSD, Biochemical Genetics Program, UCSD.
Support for this research includes funding from the Juvenile Diabetes Research Foundation, the National Institute of Diabetes and Digestive and Kidney Disease, the Folkhalsan Research Foundation, the Wilhelm and Else Stockmann Foundation, the Liv och Halsa Foundation, the UCSD Christini Fund, the Wright Family Foundation, the Lennox Foundation, the Else Kroner-Fresnius Foundation, the Swiss National Center of Competence in Research and National Institutes of Health grants P41 GM103505 and P50 GM085764.
Urine biomarkers reveal mitochondrial dysfunction in diabetic kidney disease
2013-10-11
ELSE PRESS RELEASES FROM THIS DATE:
Researchers discover innate virus-killing power in mammals
2013-10-11
RIVERSIDE, Calif. — Scientists have a promising new approach to combating deadly human viruses thanks to an educated hunch by University of California, Riverside microbiology professor Shou-Wei Ding, and his 20 years of research on plants, fruit flies, nematodes and mice to prove his theory true.
Researchers led by Ding, who heads a lab in UC Riverside's Institute for Integrative Genome Biology, have discovered that, like plants and invertebrate animals, mammals use the RNA interference (RNAi) process to destroy viruses within their own cells.
Their findings will be ...
Ancient DNA unravels Europe's genetic diversity
2013-10-11
Ancient DNA recovered from a time series of skeletons in Germany spanning 4,000 years of prehistory has been used to reconstruct the first detailed genetic history of modern-day Europeans.
The study, published today in Science, reveals dramatic population changes with waves of prehistoric migration, not only from the accepted path via the Near East, but also from Western and Eastern Europe.
The research was a collaboration between the Australian Centre for Ancient DNA (ACAD), at the University of Adelaide, researchers from the University of Mainz, the State Heritage ...
New theory of synapse formation in the brain
2013-10-11
Jülich, 10 October 2013 – The human brain keeps changing throughout a person's lifetime. New connections are continually created while synapses that are no longer in use degenerate. To date, little is known about the mechanisms behind these processes. Jülich neuroinformatician Dr. Markus Butz has now been able to ascribe the formation of new neural networks in the visual cortex to a simple homeostatic rule that is also the basis of many other self-regulating processes in nature. With this explanation, he and his colleague Dr. Arjen van Ooyen from Amsterdam also provide ...
International team uncovers mechanism for natural plant immunity
2013-10-11
Scientists in Norwich and China have, for the first time, uncovered exactly how an immune receptor mediating plants' natural immunity to bacteria works.
The research has important implications for developing broad-spectrum disease resistance in crops.
UK researchers at The Sainsbury Laboratory in Norwich, in a close collaboration with Chinese scientists at Tsinghua University and the Chinese Academy of Sciences in Beijing have shared their findings in a paper published this week in Science.
TSL senior scientist Prof. Cyril Zipfel said: "Plants, like humans, have an ...
Study finds high-risk travelers account for nearly 1 in 5 persons seeking pre-travel advice
2013-10-11
(Boston) -- Researchers from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) and Boston Medical Center (BMC) have found that high-risk travelers account for nearly 20 percent of patients using the five clinics of the Boston Area Travel Medicine Network (BATMN). The study, which appears online in Mayo Clinic Proceedings, also found that these travelers often visited destinations with malaria and typhoid risk.
In 2010, an estimated 935 million travelers crossed international borders, including 28.5 million from the U.S. Certain travelers are at greater ...
Iron in the Earth's core weakens before melting
2013-10-11
The iron in the Earth's inner core weakens dramatically before it melts, explaining the unusual properties that exist in the moon-sized solid centre of our planet that have, up until now, been difficult to understand.
Scientists use seismic waves - pulses of energy generated during earthquakes - to measure what is happening in the Earth's inner core, which at 6000 km beneath our feet is completely inaccessible.
Problematically for researchers, the results of seismic measurements consistently show that these waves move through the Earth's solid inner core at much slower ...
Kissing helps us find the right partner -- and keep them
2013-10-11
What's in a kiss? A study by Oxford University researchers suggests kissing helps us size up potential partners and, once in a relationship, may be a way of getting a partner to stick around.
'Kissing in human sexual relationships is incredibly prevalent in various forms across just about every society and culture,' says Rafael Wlodarski, the DPhil student who carried out the research in the Department of Experimental Psychology at Oxford University. 'Kissing is seen in our closest primate relatives, chimps and bonobos, but it is much less intense and less commonly used. ...
Newly discovered gene regulator could precisely target sickle cell disease
2013-10-11
Boston, Mass., October 10, 2013 – A research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production.
The researchers—led by Daniel Bauer, MD, PhD, and Stuart Orkin, MD, of Dana-Farber/Boston Children's—reported their findings today in Science.
Prior work by Orkin and others has shown that when flipped ...
European hunter-gatherers and immigrant farmers lived side-by-side for more than 2,000 years
2013-10-11
Hunter-gatherers and immigrant farmers lived side-by-side for more than 2,000 years in Central Europe, before the hunter-gatherer communities died out or were absorbed into the farming population.
In a paper published today in Science, researchers describe their analysis of DNA and isotopes from human bones found in the 'Blätterhöhle' cave near Hagen in Germany, where both hunter-gatherers and farmers were buried.
The team, led by anthropologist Professor Joachim Burger of the Johannes Gutenberg University, Germany, used stable isotopes to determine their diet, DNA ...
Study finds no increased risk of suicide in patients using smoking cessation drugs
2013-10-11
A study to assess whether patients prescribed smoking cessation drugs are at an increased risk of suicide, self-harm and treated depression compared with users of nicotine replacement therapy (NRT) has found no evidence of an increased risk. The findings, led by researchers from the University of Bristol, are published online in the British Medical Journal [BMJ] today [11 October].
Varenicline (brand name Champix in the UK, Chantix in the US) is widely used by patients seeking to stop smoking with recent figures showing there were one million prescriptions for the drug ...